EKTAF - Elekta and Philips boost existing partnership in precise and individualized oncology care solutions

Elekta (EKTAF) and Royal Philips (PHG) has extended their partnership to advance comprehensive and personalized cancer care by leveraging their capabilities to pursue integrated vendor-agnostic solutions, enhancing interoperability between the two parties' systems and software in order to drive precision in oncology. The partnership intends to further deliver a superior experience in diagnosis and adaptive, personalized treatments for clinicians, shorter treatment times and more precise therapy for patients, and lowered costs of care for healthcare providers. Gustaf Salford, Elekta's President and CEO said, "Together, we'll combine advanced informatics and image-guided RT solutions to deliver greater precision in oncology. This means easier selection by clinicans of the optimal treatment strategy and more efficient and effective therapy delivery."

For further details see:

Elekta and Philips boost existing partnership in precise and individualized oncology care solutions